Academic Journal
Q3Hematology/ Oncology and Stem Cell Therapy
About Hematology/ Oncology and Stem Cell Therapy
Hematology/ Oncology and Stem Cell Therapy is a scholarly journal published by Wolters Kluwer Health. SCImago 2025 lists it in Q3, with an SJR of 0.506 and H-index of 34.
Coverage: 2008-2025. Research categories: Hematology (Q3); Medicine (miscellaneous) (Q3); Oncology (Q3).
Open-access policies and author information
Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2026-02-12. This snapshot does not establish today’s listing status or fee quotation.
Publisher policy links recorded by DOAJ
- Aims and scope ↗
- Editorial board ↗
- Instructions for authors ↗
- Peer-review policy ↗
- Publication fees ↗
- Licence terms ↗
- Copyright policy ↗
- Preservation policy ↗
Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.
Source-backed journal facts
Topics in published research
Hematopoietic Stem Cell Transplantation; Acute Myeloid Leukemia Research; Lymphoma Diagnosis and Treatment; Acute Lymphoblastic Leukemia research; Hemoglobinopathies and Related Disorders; Chronic Lymphocytic Leukemia Research.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Revisiting autologous stem cell transplantation for LBCL in the CAR T-Cell era
Mostafa F. Mohammed Saleh, Abdulwahab A. Albabtain, Ahmed Kotb Abdrabou, Ali Nasser et al.
2026-07-22 · DOI: 10.4103/hemoncstem.hemoncstem-d-26-00022From Spirometry to Survival: Ambiguities in Pulmonary Metrics for Cellular Therapy Outcomes
Joseph Van Galen, Jared A. Daar, Usama Gergis, Henry Fung et al.
2026-07-22 · DOI: 10.4103/hemoncstem.hemoncstem-d-26-00026Characteristic and Clinical Outcomes of Localized Gastric Cancer: A Real-World Experience
Amal Aljuhani, Mohamed Aseafan, Ali Sheikh, Ali Alhanash et al.
2026-03-13 · DOI: 10.4103/hemoncstem.hemoncstem-d-25-00040Progressive transformation of germinal centers: Bridging clinical and pathological insights for diagnostic precision
Chokri Ben Lamine, Nasir A. Bakshi, Shamayel Mohammed, Riad El Fakih et al.
2026-01 · DOI: 10.4103/hemoncstem.hemoncstem-d-25-00052The Two-Step Allogeneic Stem Cell Transplant Is Associated with Excellent Engraftment, Improved Survival and Low Nonrelapse Mortality in Patients with Myelofibrosis
Xia Bi, Shaik Rashid, Joanne Filicko-O'Hara, Joseph Van Galen et al.
2026-01 · DOI: 10.4103/hemoncstem.hemoncstem-d-25-00039Cancer epidemiology in the Kingdom of Saudi Arabia, 2024
Mahmoud Aljurf, Nahar Al-Azemi, Ali Saeed Al-Zahrani, Yasmin Altwaijri et al.
2026-01 · DOI: 10.4103/hemoncstem.hemoncstem-d-26-00008Impact of mental health on outcomes of patients with relapsed and/or refractory diffuse large B-cell lymphoma treated with chimeric antigen receptor T-cell therapy
Mohamed A. Kharfan-Dabaja, Athanasios Tsalatsanis, Mehmet S. Uyanik, Taimur Sher et al.
2026-01 · DOI: 10.4103/hemoncstem.hemoncstem-d-26-00018Hypophosphatemia as a Marker for Immune Effector Cell-Associated Neurotoxicity Syndrome in Chimeric Antigen Receptor T Cell Recipients
Abedalrahman Almashayekh, Samia Sulaiman, Abdallah Alaarag, Rahaf Omaish et al.
2026-01 · DOI: 10.4103/hemoncstem.hemoncstem-d-25-00048Epidemiology and Outcomes of Hospitalized Patients with Hematological Malignancy and Acute Respiratory Failure
Anoosha Ponnapalli, Aditya Sharma, Mariam Fatima, Avneet Kaur Arora et al.
2025-10 · DOI: 10.4103/hemoncstem.hemoncstem-d-25-00032Epidemiology and Outcomes of Hepatic Veno-Occlusive Disease after Allogeneic Hematopoietic Stem Cell Transplantation: A Descriptive Analysis of the U.S. National Inpatient Sample
Aditya Sharma, Sarvani Surapaneni, Aditi Sharma, Rahul Maheshwari et al.
2025-10 · DOI: 10.4103/hemoncstem.hemoncstem-d-25-00043Patients with Fanconi Anemia Have an Increased Incidence of Diabetes Mellitus After Allogeneic Stem Cell Transplantation
Mouhab Ayas, Khawar Siddiqui, Abdullah Al-Jefri, Ibrahim Ghemlas et al.
2025-10 · DOI: 10.4103/hemoncstem.hemoncstem-d-25-00050Effect of Somatic Variants Post Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia and Myelodysplastic Syndrome
Madiha Iqbal, Himil Mahadevia, Zhuo Li, Sophia Blumenfeld et al.
2025-10 · DOI: 10.4103/hemoncstem.hemoncstem-d-25-00029Antibody-Drug Conjugates (ADCs) for Breast Cancer Therapeutic Landscape: Concept and Mechanisms of Action
Roberto Paz-Manrique, Joseph A. Pinto, Henry L. Gomez Moreno
2025-10 · DOI: 10.4103/hemoncstem.hemoncstem-d-24-00042Impact of TMPRSS6 gene polymorphism on iron overload among children with sickle cell disease
Eman A. El-Bostany, Eman A. Elghoroury, Eman H. Thabet, Nehal Abdelhamid et al.
2025-09-12 · DOI: 10.4103/hemoncstem.hemoncstem-d-25-00002Patterns of Graft-Versus-Host Disease (GvHD) Prevention Practices in the Eastern Mediterranean (EM) Region: A Worldwide Network for Blood & Marrow Transplantation (WBMT) Global Study
Ibrahim N. Muhsen, Dietger Niederwieser, Laurent Garderet, Olaf Penack et al.
2025-09-12 · DOI: 10.4103/hemoncstem.hemoncstem-d-25-00004Allogeneic hematopoietic cell transplantation as the standard of care for blastic plasmacytoid dendritic cell neoplasm in first complete remission
Mohamed A. Kharfan-Dabaja
2025-09-12 · DOI: 10.4103/hemoncstem.hemoncstem-d-25-00023Epidemiology and outcomes of hospitalized patients with lung cancer and acute respiratory failure: National inpatient database analysis
Martina Tripcovici, Aditya Sharma, Brittni J. Clopton, Daniel Kurtz et al.
2025-09-12 · DOI: 10.4103/hemoncstem.hemoncstem-d-25-00025Myeloablative and Reduced Intensity Allogeneic Transplant in Patients with Myeloproliferative Neoplasms
Andrew D. Trunk, Yanwen Chen, Aaron T. Gerds, Akriti Jain et al.
2025-09-12 · DOI: 10.4103/hemoncstem.hemoncstem-d-25-00008A Critical Review of CAR-T Therapies for Glioblastoma: What’s Wrong with the Current Attempts?
Sergei V. Belokon, Valeriya A. Kukarskaya, Ilya D. Klabukov, Victoria A. Shestakova et al.
2025-04 · DOI: 10.4103/hemoncstem.hemoncstem-d-24-00040Outcomes of Matched Sibling and Haploidentical Donors Hematopoietic Stem Cell Transplantation for Pediatric Severe Aplastic Anemia: A Retrospective Multicenter Study
Diego Medina Valencia, Natalia Builes, Alexis A. Franco, Angela Trujillo et al.
2025-04 · DOI: 10.4103/hemoncstem.hemoncstem-d-24-00037Reviews
Community Reviews
Version History
October 2, 2026 at 9:26 pm
October 2, 2026